Series C funding round for PhaseBio Pharmaceuticals raising $40M in March 2015
Series C funding round for PhaseBio Pharmaceuticals raising $40M in March 2015
| Investor | Firm Type | Partner |
|---|
AstraZeneca R&DLEAD | Private | — |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | James Barrett |
This company has completed 5 funding rounds. Current round is highlighted.
Total Raised
$129M
Top Valuation
-
PhaseBio Pharmaceuticals raised $40M in a Series C round.
The round was announced on 03/01/15.
The round was led by Michael Gutch.